Atlas Trials

Effect of Methylphenidate on Cancer-related Cognitive Impairment

Clinical trial NCT02970500 · TERMINATED

Trial details

NCT number
NCT02970500
Sponsor
CHU de Quebec-Universite Laval
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer FemaleCancer-Related Condition
Start date
2017-10-09
Primary completion
2022-12-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.